Merrimack Pharmaceuticals Inc: SCHEDULE 13G filed Feb 22, 2024

Form type
SCHEDULE 13G
Filing date
Feb 22, 2024
Accession number
0001758866-24-000002
Filer
Merrimack Pharmaceuticals Inc (CIK 1274792)